According to the Washington Post, at least 390,000 students were exposed to a school shooting (exposure is defined as students attending a school at which a shooting occurred during the current school year) since the 1999 Columbine shooting. This brief analyzes the rate of student exposure to school shootings over time at the national and…
Through a new partnership, employees of BetterHelp’s employer clients can access Talkiatry’s psychiatry services on an in-network basis at no extra cost. The post BetterHelp, Talkiatry Collaborate To Offer Psychiatric Services to Employers appeared first on MedCity News.
While opioid overdoses have been rising for decades, trends in most recent times provide us a glimmer of hope. NPR reports: For the first time in decades, public health data shows a sudden and hopeful drop in drug overdose deaths across the U.S.“This is exciting,” said Dr. Nora Volkow, head of the National Institute On…
The clinical trial process is complex, long, and always arduous. But the results of the drug development process can be amazing, new, safe, effective, life-changing, and life-enhancing therapies. The post Challenges and Opportunities for Digital Innovation in Clinical Trials appeared first on MedCity News.
There’s a new health innovation law firm in town! Rebecca Gwilt & Kaitlyn O’Connor have started Elevare Law to help health tech companies. We spent a little time talking about the new firm and who it’s going to work with, and a lot about the different legal and regulatory challenges facing digital health companies. Deep…
As President Trump would have most certainly learned on his first day at Wharton, you really have to spend money to make money. If you want to make America truly a world leader, why on earth would you stifle the institution that contributed an estimated $92.89 billion to the US economy in 2023 alone and…
Truth is, there are hugely positive tailwinds at our back. But the way we’ve been thinking about the problem is holding us back from solving it. Here’s why. The post Dear Mr. Buffett: Healthcare Isn’t Hopeless appeared first on MedCity News.
By MATTHEW HOLT There’s been a lot of discussion lately about whether digital health is a legitimate place for venture capital. There have been lots of huge failures, very few notable successes (and certainly no “biggest companies in the world” yet, while some real giants (Walmart/Walgreens/Amazon) have come in and then got out of health…
By acquiring Dermavant, Organon gets Vtama, a drug approved for treating plaque psoriasis. An FDA decision for the topical cream in atopic dermatitis is expected by the end of 2024. The post Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary appeared first on MedCity News.
In the U.S., Hispanic/Latino people have been disproportionately affected by HIV since the epidemic’s beginning, and that disparity has deepened over time. Hispanic/Latino people represent a larger share of HIV diagnoses and people estimated to be living with HIV relative to their population size. This fact sheet provides an overview of the impact of HIV…